Headline News

 

Novo Nordisk files for approval of a higher dose of Wegovy injection 7.2 mg

Posted on December 02, 2025

Sonrotoclax granted priority review by the U.S. FDA for the treatment of relapsed or refractory mantle cell lymphoma

Posted on December 02, 2025

Roche receives FDA clearance for its point-of-care test for diagnosing Bordetella infections

Posted on December 02, 2025

Regeneron and Tessera Therapeutics set to develop TSRA-196 for alpha-1 antitrypsin deficiency

Posted on December 02, 2025

Bayer’s Asundexian meets primary efficacy and safety endpoints in phase III OCEANIC-STROKE study

Posted on December 02, 2025

Bayer begins phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia

Posted on December 02, 2025

AbbVie set to present phase 3 ECLIPSE data highlighting atogepant superiority over placebo

Posted on December 02, 2025

Imfinzi approved as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers

Posted on December 02, 2025

Zepbound single-dose vials price lowered

Posted on December 02, 2025

Dupixent approved as the first targeted medicine for chronic spontaneous urticaria in the EU

Posted on December 02, 2025

AstraZeneca’s $2 billion manufacturing investment in Maryland

Posted on November 25, 2025

Astrazeneca’s Koselugo approved for adults with neurofibromatosis type 1 in the US

Posted on November 25, 2025

EPKINLY in combination with Rituximab and Lenalidomide approved for relapsed or refractory follicular lymphoma

Posted on November 25, 2025

Bristol Myers Squibb receives approval to expand use of CAR T Cell Therapy Breyanzi for relapsed or refractory mantle cell lymphoma

Posted on November 25, 2025

GSK and LTZ announce collaboration to advance novel myeloid cell engagers in oncology

Posted on November 25, 2025